Inside Innovation

Seattle-based Athira Pharma announced that it received a three-year grant totaling $15 million from the National Institute on Aging. The funding will support an upcoming clinical

Washington State University in Spokane announced the opening of Spinout Space, or Sp3nw, a life sciences incubator for launching startups. The goal of Sp3nw is

Seattle-based Silverback Therapeutics more than doubled its original IPO hopes with a $242 million debut on the Nasdaq Stock Market. Originally shooting for a $100

Bothell-based Ventec Life Systems, one of the few ventilator manufacturers in the U.S., pulled off a massive feat earlier this year when it partnered with

Umoja Biopharma, a startup founded last year by Seattle biotech veteran Andy Scharenberg, announced that it has raised $53 million in a recent Series A

Seattle Children’s Hospital, consistently ranked as one of the best children’s hospitals in the U.S., has launched a new endeavor: Seattle Children’s Therapeutics. This research institution

Following its August 2020 pledge to allocate $300 million over the next five years to diversity initiatives, Bristol Myers Squibb announced that $100 million of that

Seattle-based Adaptive Biotechnologies has developed a new type of COVID-19 test that uses a blood sample to determine immune response to the virus. The test

Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein Printing” technology is used to

CBRE named Seattle’s life science industry one of the top in the nation, according to a recent report. Ranked ninth, Seattle brought in record venture

Fueled by unparalleled access to technology and a strong foundation of excellence in research, the life science industry in the Puget Sound region has grown

New census data shows that the number of Seattleites employed in STEM fields has more than doubled over the past decade, hitting almost 89,700 in